NRC
DFTX

New Republic Capital’s Definium Therapeutics DFTX Stock Holding History

New Republic Capital’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
+5,175
New +$128K 0.06% 247

Other funds holding DFTX

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

New Republic Capital's DFTX Position: Q2 2026 in Review

New Republic Capital opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 5,175 shares worth $243K. The stake represents 0.06% of the portfolio and ranks #247 among its holdings.

115 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • New Republic Capital held 5,175 shares of Definium Therapeutics worth $243K as of Q2 2026.
  • Definium Therapeutics was a new New Republic Capital position in Q2 2026.
  • Definium Therapeutics made up 0.06% of New Republic Capital's portfolio in Q2 2026, its #247 holding.
  • 115 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.